Tucson AZ 超重临床试验
17项针对 超重的研究正在 Tucson及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
招募中3 期
- Arizona Clinical Trials, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Arizona Clinical Trials, Tucson
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Tucson Clinical Research Institute, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- Tucson Clinical Research Institute, Tucson
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
招募中3 期
- Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
招募中3 期
- Noble Clinical Research, LLC, Tucson
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
招募中3 期
- University of Arizona, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Tucson
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Arizona Clinical Trials /ID# 282372, Tucson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期欢迎健康志愿者
- ACCOMPLISH-2 Research Site, Tucson
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Tucson
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Tucson
其他城市的 超重试验
- San Antonio, TX34 项研究
- Houston, TX33 项研究
- Chicago, IL29 项研究
- Orlando, FL27 项研究
- Dallas, TX23 项研究
- Miami, FL23 项研究
- Washington, DC20 项研究
- Atlanta, GA20 项研究
- Austin, TX19 项研究
- Las Vegas, NV19 项研究
- Jacksonville, FL19 项研究
- New York City, NY19 项研究
Tucson的其他研究
- 肥胖症20 项研究
- 乳腺癌18 项研究
- 非小细胞肺癌18 项研究
- 转移性癌症14 项研究
- 2型糖尿病13 项研究
- 癌症（所有类型）12 项研究
- 前列腺癌12 项研究
- 结直肠癌11 项研究
- 心血管疾病11 项研究
- 脂肪性肝病10 项研究
- 急性髓系白血病10 项研究
- 高血压10 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。